These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 11963941)

  • 21. Once more confirmed: adjuvant radiotherapy and improved local control provide a significant survival benefit for early breast cancer patients.
    Sautter-Bihl ML; Sauer R
    Strahlenther Onkol; 2006 Apr; 182(4):199-201. PubMed ID: 16622620
    [No Abstract]   [Full Text] [Related]  

  • 22. Three methods for minimally important difference: no relationship was found with the net proportion of patients improving.
    Lemieux J; Beaton DE; Hogg-Johnson S; Bordeleau LJ; Goodwin PJ
    J Clin Epidemiol; 2007 May; 60(5):448-55. PubMed ID: 17419955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ten years of experience with weekly chemotherapy in metastatic breast cancer patients: multivariate analysis of prognostic factors.
    Nisticò C; Cuppone F; Bria E; Fornier M; Giannarelli D; Mottolese M; Novelli F; Natoli G; Cognetti F; Terzoli E
    Anticancer Drugs; 2006 Nov; 17(10):1193-200. PubMed ID: 17075319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Women's perceptions of the effectiveness of telephone support and education on their adjustment to breast cancer.
    Chamberlain Wilmoth M; Tulman L; Coleman EA; Stewart CB; Samarel N
    Oncol Nurs Forum; 2006 Jan; 33(1):138-44. PubMed ID: 16470242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychotherapy does not promote survival (Kissane et al., 2007): now what?
    Coyne JC; Hanisch LJ; Palmer SC
    Psychooncology; 2007 Nov; 16(11):1050-2. PubMed ID: 17937383
    [No Abstract]   [Full Text] [Related]  

  • 26. Update on the NSABP and ACOSOG breast cancer sentinel node trials.
    White RL; Wilke LG
    Am Surg; 2004 May; 70(5):420-4. PubMed ID: 15156950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sentinel-node biopsy in breast cancer.
    De Salvo GL; Del Bianco P; Zavagno G
    N Engl J Med; 2003 Nov; 349(20):1968-71; author reply 1968-71. PubMed ID: 14626250
    [No Abstract]   [Full Text] [Related]  

  • 28. Breast cancer: non-metastatic.
    Dixon JM; Gregory K; Johnston S; Rodger A
    Clin Evid; 2002 Jun; (7):1603-30. PubMed ID: 12230775
    [No Abstract]   [Full Text] [Related]  

  • 29. Emotional expression and diurnal cortisol slope in women with metastatic breast cancer in supportive-expressive group therapy: a preliminary study.
    Giese-Davis J; DiMiceli S; Sephton S; Spiegel D
    Biol Psychol; 2006 Aug; 73(2):190-8. PubMed ID: 16750288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An interactive process model of psychosocial support needs for women living with breast cancer.
    Marlow B; Cartmill T; Cieplucha H; Lowrie S
    Psychooncology; 2003 Jun; 12(4):319-30. PubMed ID: 12748970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of care by breast cancer patients participating or not participating in a randomized controlled trial: a report with the Patients' Committee for Clinical Trials of the Ligue Nationale Contre le Cancer.
    Julian-Reynier C; Genève J; Dalenc F; Genre D; Monnier A; Kerbrat P; Largillier R; Serin D; Rios M; Roché H; Jimenez M; Tarpin C; Maraninchi D;
    J Clin Oncol; 2007 Jul; 25(21):3038-44. PubMed ID: 17536083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Latest studies hint at survival advantage with aromatase inhibitors in early breast cancer.
    Tuma RS
    J Natl Cancer Inst; 2006 Jan; 98(2):86-7. PubMed ID: 16418506
    [No Abstract]   [Full Text] [Related]  

  • 33. [The 4th large meta-analysis of all trials of the treatment of operable breast cancer: increased survival after a longer follow-up].
    van Nes JG; Nortier WR; van de Velde CJ
    Ned Tijdschr Geneeskd; 2005 Sep; 149(36):1978-80. PubMed ID: 16171107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is there a future in psychosocial predictive factors in breast cancer?
    Osborne R
    Eur J Cancer; 2005 Aug; 41(12):1665-6. PubMed ID: 15964183
    [No Abstract]   [Full Text] [Related]  

  • 35. Adjuvant clodronate in breast cancer.
    Paterson AH
    Acta Oncol; 2005; 44(1):80-2; author reply 83-4. PubMed ID: 15848910
    [No Abstract]   [Full Text] [Related]  

  • 36. Estimates of clinically useful measures in competing risks survival analysis.
    Ambrogi F; Biganzoli E; Boracchi P
    Stat Med; 2008 Dec; 27(30):6407-25. PubMed ID: 18937229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Re: Role of detection method in predicting breast cancer survival: analysis of randomized screening trials.
    Paci E; Ponti A; Crocetti E; Zappa M; Segnan N
    J Natl Cancer Inst; 2005 Dec; 97(24):1853-4; author reply 1854. PubMed ID: 16368949
    [No Abstract]   [Full Text] [Related]  

  • 38. [High-dose chemotherapy for metastatic breast cancer].
    Lalle M; De Rosa L; Perillo A; Scambia G; D'Aprile M; Antimi M
    Clin Ter; 2004; 155(7-8):305-15. PubMed ID: 15553258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving the outcome for older women with breast cancer.
    Fentiman IS
    Br J Surg; 2004 Jun; 91(6):655-6. PubMed ID: 15164431
    [No Abstract]   [Full Text] [Related]  

  • 40. Sentinel-node biopsy in breast cancer.
    McMasters KM
    N Engl J Med; 2003 Nov; 349(20):1968-71; author reply 1968-71. PubMed ID: 14626252
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.